Treatment of Trichomoniasis in Pregnancy
Pregnant women with trichomoniasis should be treated with metronidazole 2 g orally as a single dose, regardless of trimester. This recommendation represents an evolution from earlier guidelines and is supported by safety data showing no teratogenic effects.
Key Treatment Recommendations
Primary Regimen
- Metronidazole 2 g orally in a single dose 1, 2
- This achieves cure rates of approximately 90-95%
- Safe throughout all trimesters of pregnancy, including the first trimester (based on more recent guidelines)
Important Context on Guideline Evolution
There is a notable shift in recommendations across the provided guidelines:
- 1993 guidelines stated metronidazole was "contraindicated in the first trimester" 3
- 1998 and 2002 guidelines removed this restriction, stating pregnant patients "can be treated with 2 g of metronidazole in a single dose" without trimester limitations 1, 2
This change reflects accumulating evidence: multiple studies and meta-analyses have not demonstrated consistent associations between metronidazole use during pregnancy and teratogenic or mutagenic effects in infants 2.
Clinical Decision-Making Algorithm
When to Treat
Symptomatic pregnant women: Treat to ameliorate symptoms 2
Asymptomatic pregnant women: The evidence is more nuanced here. While trichomoniasis is associated with adverse pregnancy outcomes (premature rupture of membranes, preterm delivery, low birthweight), treating asymptomatic infection does not reduce these risks 2, 4. One randomized trial actually showed treatment of asymptomatic trichomoniasis increased preterm delivery rates (19.0% vs 10.7%, relative risk 1.8) 4. However, symptomatic treatment remains warranted 5.
Partner Management
- Sex partners must be treated 1, 2
- Instruct patients to abstain from sexual intercourse until both partners complete therapy and are asymptomatic
- Partner treatment enhances cure rates significantly 5
Treatment Failure Management
If initial treatment fails:
- First failure: Re-treat with metronidazole 500 mg twice daily for 7 days 2
- Second failure: Metronidazole 2 g once daily for 3-5 days 2
- Persistent failure: Consult specialist; consider susceptibility testing for metronidazole resistance 2
Critical Pitfalls to Avoid
Do not use topical metronidazole gel - it does not achieve therapeutic levels in the urethra or perivaginal glands and is ineffective for trichomoniasis 1
Do not skip partner treatment - this is a major cause of treatment failure and reinfection
Do not routinely screen and treat asymptomatic pregnant women - evidence shows this may paradoxically increase preterm delivery risk 4
Follow-Up
- Routine test of cure is unnecessary for asymptomatic patients after treatment 1, 2, 5
- However, retesting is recommended given high reinfection rates (24-33% positivity at retest) 6
- If symptoms persist, re-evaluate for treatment failure or reinfection
Special Considerations
Metronidazole Allergy
- Desensitization is possible for immediate-type allergies 2
- Topical alternatives have cure rates <50% and are not recommended 2
- No effective alternatives to nitroimidazoles exist 3
HIV Co-infection
Pregnant women with HIV and trichomoniasis receive the same treatment regimen 1, 2